BioCardia (BCDA) Revenue Growth (3y) (2016 - 2024)
Powered by 
Analysis
BioCardia (BCDA) Revenue Growth (3y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 647.27% |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 74.18% |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | 15.38% |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 19.04% |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -64.84% |
| Mar 31, 2024 | 6.14% |
| Dec 31, 2023 | -34.38% |
| Sep 30, 2023 | 118.98% |
| Jun 30, 2023 | 16.78% |
| Mar 31, 2023 | 18.98% |
| Dec 31, 2022 | -21.00% |
| Sep 30, 2022 | 3.00% |
| Jun 30, 2022 | 124.57% |
| Mar 31, 2022 | -34.75% |
| Dec 31, 2021 | -8.46% |
| Sep 30, 2021 | 113.81% |
| Jun 30, 2021 | -33.91% |
| Mar 31, 2021 | -38.63% |
| Dec 31, 2020 | -22.81% |
| Sep 30, 2020 | -36.05% |
| Jun 30, 2020 | -37.76% |
| Mar 31, 2020 | -34.78% |
| Dec 31, 2019 | 16.21% |
| Sep 30, 2019 | 18.36% |